Patents by Inventor Michael HINGAR

Michael HINGAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IN VITRO GLYCOENGINEERING OF ANTIBODIES
    Publication number: 20240101643
    Abstract: Herein is reported a method for producing an antibody comprising the steps of forming an antibody-antibody light chain affinity ligand complex, wherein the antibody light chain affinity ligand is immobilized on a solid phase, by applying a solution comprising the antibody to the immobilized antibody light chain affinity ligand, and incubating the complex formed in the previous step with one or more enzymes to modify the glycosylation of the antibody, thereby producing the antibody.
    Type: Application
    Filed: May 16, 2023
    Publication date: March 28, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Roberto FALKENSTEIN, Heiko WALCH, Sebastian MALIK, Marco THOMANN, Matthias FREIHERR VON ROMAN, Ingrid GRUNERT, Roland DORN, Michael HINGAR
  • IN VITRO GLYCOENGINEERING OF ANTIBODIES
    Publication number: 20200165320
    Abstract: Herein is reported a method for producing an antibody comprising the steps of forming an antibody-antibody light chain affinity ligand complex, wherein the antibody light chain affinity ligand is immobilized on a solid phase, by applying a solution comprising the antibody to the immobilized antibody light chain affinity ligand, and incubating the complex formed in the previous step with one or more enzymes to modify the glycosylation of the antibody, thereby producing the antibody.
    Type: Application
    Filed: June 20, 2019
    Publication date: May 28, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Roberto FALKENSTEIN, Heiko WALCH, Sebastian MALIK, Marco THOMANN, Matthias FREIHERR VON ROMAN, Ingrid GRUNERT, Roland DORN, Michael HINGAR